IPP Bureau
Hyperfine bringing Swoop to India through distribution partnership with Radiosurgery Global
By IPP Bureau - May 30, 2024
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
FDA grants priority review to Merck’s application for Keytruda plus chemotherapy for metastatic malignant pleural mesothelioma
By IPP Bureau - May 30, 2024
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
Valent BioSciences opens new addition at Melnik and Shafer Biorational Research Center
By IPP Bureau - May 30, 2024
Greg was also central to the planning, design, and construction of this facility
Merck KGaA to set up € 300 million Bioprocessing Production Center in South Korea
By IPP Bureau - May 30, 2024
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Alembic Pharmaceuticals receives USFDA final approval for Sacubitril and Valsartan Tablets
By IPP Bureau - May 30, 2024
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Merck to acquire EyeBio for US$ 1.3 billion upfront payment
By IPP Bureau - May 30, 2024
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Lilly increases manufacturing investment to US$ 9 billion at newest Indiana site
By IPP Bureau - May 29, 2024
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Strides receives USFDA approval for Sucralfate oral suspension, 1gm/10 mL
By IPP Bureau - May 29, 2024
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1
By IPP Bureau - May 29, 2024
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth
By IPP Bureau - May 29, 2024
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
Bluecrux supports Sanofi in harnessing AI to transform supply chains
By IPP Bureau - May 28, 2024
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
Roche and Hitachi High-Tech extend partnership for further breakthroughs in diagnostic testing
By IPP Bureau - May 28, 2024
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Ascentage releases results from multiple clinical studies of its lead drug candidates
By IPP Bureau - May 28, 2024
These abstracts report on the company's three lead drug candidates, including olverembatinib
AstraZeneca India posts FY 2023-24 revenue higher at Rs. 1,330 Cr
By IPP Bureau - May 28, 2024
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
